Abstract:OBJECTIVE:To investigate the pharmacokinetics and bioavailability of ziprasidone tablets in Chinese healthy volunteers.METHODS:A randomized crossover study was performed in 20 healthy volunteers, who received a single oral dose (40 mg) of the test or reference preparation of ziprasidone. Blood samples were collected from the subjects at different time points following the drug administration, and the plasma concentration of ziprasidone was determined using high-performance liquid chromatography. The pharmacokinetic parameters were analyzed by DAS software and the relative bioavailability was calculated according to the formula F=AUC(t)/AUC(r)x100%.RESULTS:For the test and reference preparation, the pharmacokinetics parameter C(max) was 170.7-/+71.3 and 174.4-/+81.6 ng/ml, t(max) 3.73-/+1.87 and 3.69-/+1.84 h, t((1/2)) 5.57-/+1.62 and 5.61-/+1.73 h, AUC(0-t) 1273-/+252.3 and 1296-/+266.9 ng.h.ml(-1), and AUC(0-infinity)1396-/+276.9 and 1407-/+281.5 ng.h.ml(-1), respectively, with the relative bioavailability of (98.3-/+12.6)%. No significant differences were found in the main parameters of the test and reference preparations as analyzed by ANOVA and two- and one-side t-test.CONCLUSION:The test and reference preparation of ziprasidone are bioequivalent.

Bioequivalence of Domestic Azithromycin Granules in Healthy Volunteers

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Study on bioequivalence of cilostazol table in healthy volunteers

Evaluation of quality consistency of enteric-coated capsule azithromycin with imported tablet of azithromycin

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

A Reference‐Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open‐Label, Randomized, Single‐Dose, 3‐Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions

Bioequivalence of erythromycin enteric-coated capsules in healthy volunteers

Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin for Suspension: A Nonblinded, Single-Dose, Randomized, Three-Way Crossover Study in Fed and Fasting States Among Healthy Chinese Volunteers

Bioequivalence of erythromycin ethylsuccinate orally disintegrating tablet in healthy volunteers

Bioequivalence study of fluoxetine capsules in healthy volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of ornidazole tablets in Chinese healthyvolunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Pharmacokinetics and Relative Bioavailability of Azithromycin Tablets

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalence of Domestic and Imported Nizatidine Formulations in Chinese Healthy Volunteers

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Bioequivalence of domestic and imported ceftibuten tablets in healthy volunteers